May 10th 2024
While Moderna expects mRNA-1345 to be approved later this month, the company cites FDA administrative constraints as reason for delay.
April 30th 2024
Your daily dose of the clinical news you may have missed.
April 22nd 2024
Researchers found that the COVID-19 booster dose elicited a 71%-84% increase in the median anti-spike half-life over that of the primary series.
March 29th 2024
Investigators found vaccine uptake of 41% among unvaccinated individuals who were part of a messaging intervention in the emergency department.
March 19th 2024
The novel 21-valent pneumococcal vaccine remains on track for the FDA PDUFA date of June 17, 2024; Merck adds this new data to the body of positive evidence.
FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine Booster for Select Groups
The Pfizer-BioNTech booster shot is authorized for use in persons aged ≥65 years, at high risk of severe disease, and who have frequent exposure to the virus increasing risk for severe infection.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 22, 2021
Data from the CDC on the Delta variant and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 21, 2021
J&J Preprint Data Show Real-world Durability, Promise for Booster Shot Against COVID-19
Strong evidence from a large, real-world evidence study, and preliminary data from a phase 3 booster-dose trial may support J&J's next steps toward FDA authorization of a COVID-19 booster.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 20, 2021
CDC: Moderna Vaccine Shows Highest Efficacy Against Hospitalizations in Healthy Adults
In a new analysis of adults without immunocompromising conditions, vaccine effectiveness against hospitalization was higher for Moderna than Pfizer and Johnson & Johnson.
Pfizer-BioNTech Report COVID-19 Vaccine is Safe, Effective in Children Aged 5 to 11 Years
Pfizer/BioNTech report "robust" antibody response to COVID-19 vaccine in children aged 5 to 11 years with safety profile comparable to that seen in persons aged 16 to 25 years.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 17, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 16, 2021
COVID-19 Hospitalizations for Unvaccinated Cost US Billions
Avoidable COVID-19 hospitalizations for unvaccinated persons in the US have cost an estimated $5 billion since June, according to a new study.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 15, 2021
10 States with the Highest COVID-19 Vaccination Rates, 5 with the Lowest
According to the CDC, Vermont right now has the highest and Wyoming the lowest percentage of its state's population fully vaccinated against COVID-19.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 13, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 10, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 9, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 7, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 2, 2021
3 Flu Vaccine Conundrums: Who Needs a Shot and When?
Who needs a flu shot and when is not always straightforward. This year it's more important than ever to know what the CDC recommends. Start with 3 short scenarios.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 1, 2021
Myocarditis as Metaphor for COVID-19 Vaccine Risk-Benefit Calculation
There is a very small risk of myocarditis after the second dose of COVID-19 mRNA vaccines. How small? And how small vs the risks associated with infection?
Flu Seasons Compared: 8 Questions on 2020-2021 and What Might Happen This Year
Test what you know about flu seasons past and what the flu season present might have in store with 8 questions based on the history. Remember: Winter is coming.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of August 31, 2021
ESC 2021: Flu Vaccine Cuts Risk of Death, Heart Attack in Patients with Heart Disease
ESC Congress 2021: Results from the largest trial of its kind suggest that flu vaccination should be part of in-hospital treatment after myocardial infarction.
The 2021-2022 Flu Vaccine: 10 Frequently Asked Questions
There is something new with the flu and the vaccine against it every year. We summarized answers to 10 questions frequently asked by patients and clinicians alike.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of August 30, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of August 27, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of August 26, 2021
7 New COVID-19 Vaccine Myths and What to Tell your Patients
SAMPLE: "Can being near a fully vaccinated person affect my menstrual cycle?" Plus 6 more COVID-19 vaccine myths patients may ask about and the facts to refute them.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of August 25, 2021
The Delta variant makes up approximately 98% of COVID-19 cases in the US, according to the latest CDC estimates.
Adult Vaccination Against Preventable Diseases Now Urgent, says NAIIS
Low rates of routine adult vaccination, reduced further during the 2020-21 pandemic months, threaten a surge in these conditions as the US reopens, says the National Adult and Influenza Immunization Summit.